$CLNN Clene moving premarket! 🚀 Up 27% 🔹 Big momentum after full-year 2025 results and major CNM-Au8 updates 📈 🔹 Type C FDA meeting expected by end of Q1 to

$CLNN Clene moving premarket! 🚀 Up 27% 🔹 Big momentum after full-year 2025 results and major CNM-Au8 updates 📈 🔹 Type C FDA meeting expected by end of Q1 to discuss latest ALS biomarker + survival data 🧠 🔹 Company plans to file NDA for CNM-Au8 in ALS under accelerated approval by end of June 2…